- Home
- CAH vs ALC Comparison
CAH vs ALC Comparison
Compare CAH & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAH
- ALC
- Stock Information
- Founded
- CAH 1979
- ALC 1945
- Country
- CAH United States
- ALC Switzerland
- Employees
- CAH N/A
- ALC N/A
- Industry
- CAH Other Pharmaceuticals
- ALC Ophthalmic Goods
- Sector
- CAH Health Care
- ALC Health Care
- Exchange
- CAH Nasdaq
- ALC Nasdaq
- Market Cap
- CAH 36.4B
- ALC 40.2B
- IPO Year
- CAH N/A
- ALC N/A
- Fundamental
- Price
- CAH $164.47
- ALC $73.60
- Analyst Decision
- CAH Buy
- ALC Buy
- Analyst Count
- CAH 14
- ALC 11
- Target Price
- CAH $161.43
- ALC $91.41
- AVG Volume (30 Days)
- CAH 2.1M
- ALC 2.2M
- Earning Date
- CAH 10-30-2025
- ALC 11-11-2025
- Dividend Yield
- CAH 1.24%
- ALC 0.29%
- EPS Growth
- CAH 86.96
- ALC N/A
- EPS
- CAH 6.45
- ALC 2.16
- Revenue
- CAH $222,578,000,000.00
- ALC $10,025,000,000.00
- Revenue This Year
- CAH $12.79
- ALC $5.94
- Revenue Next Year
- CAH $7.93
- ALC $7.71
- P/E Ratio
- CAH $25.50
- ALC $34.39
- Revenue Growth
- CAH N/A
- ALC 4.04
- 52 Week Low
- CAH $106.98
- ALC $71.55
- 52 Week High
- CAH $168.44
- ALC $99.20
- Technical
- Relative Strength Index (RSI)
- CAH 66.78
- ALC 39.58
- Support Level
- CAH $158.70
- ALC $71.55
- Resistance Level
- CAH $157.64
- ALC $77.01
- Average True Range (ATR)
- CAH 2.79
- ALC 1.17
- MACD
- CAH 0.71
- ALC 0.20
- Stochastic Oscillator
- CAH 98.13
- ALC 37.55
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.